Advancing Early Neuroscience Trials Through Integrated Biomarkers & Smarter P1b Design
- How combining multimodal biomarkers can strengthen proof of mechanism for early neuroscience programs
- Approaches for designing P1b trials that capture signal in psychiatry–neurology overlap indications
- Lessons from industry on executing efficient early phase studies with limited resources
- Opportunities to accelerate CIAS, BPD, and emerging neuropsychiatric assets through unified translational frameworks